Canada markets closed

LLY Feb 2025 660.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
279.200.00 (0.00%)
At close: 09:48AM EDT
Full screen
Previous Close279.20
Open279.20
Bid181.30
Ask187.20
Strike660.00
Expire Date2025-02-21
Day's Range279.20 - 279.20
Contract RangeN/A
Volume2
Open Interest3
  • Yahoo Finance

    What end of Eli Lilly's weight-loss drug shortage means for the competition

    The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. What does that mean for the marketplace?

  • Yahoo Finance Video

    Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list

    Eli Lilly's (LLY) GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list. Yahoo Finance Senior Health Reporter Anjalee Khemlani reports more on the story and what it means for competitors, like Novo Nordisk (NVO). For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Melanie Riehl

  • Zacks

    Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know

    Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close.